• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未成熟的PIT1谱系垂体神经内分泌肿瘤/腺瘤,一种形态学上独特的垂体神经内分泌肿瘤/腺瘤,通常具有细胞学异型性特征且倾向于具有侵袭性的临床潜能。

Immature PIT1-lineage Pituitary Neuroendocrine Tumors/Adenomas, a Morphologically Unique Pituitary Neuroendocrine Tumors/Adenomas Commonly With Cytologic Atypia Features and a Predilection for Aggressive Clinical Potential.

作者信息

Lang Yuejiao, Guo Shaolei, Tuo Ying, Tian Tian, Wang Yuefeng, Li Qiming, Chen Yingqian, Chen Wenli, Zhu Yonghong, Liu Dawei

机构信息

Departments of Pathology.

Neurosurgery.

出版信息

Am J Surg Pathol. 2025 Mar 1;49(3):243-250. doi: 10.1097/PAS.0000000000002339. Epub 2024 Dec 17.

DOI:10.1097/PAS.0000000000002339
PMID:39688088
Abstract

Immature PIT1-lineage pituitary neuroendocrine tumors (PitNETs)/adenomas (Immature PIT1-lineage tumors) are a rare and underrecognized subtype of PitNETs that exhibits distinct cytologic atypia features and aggressive clinical potential. This study characterizes the clinical, radiological, histologic, and immunohistochemical features of 15 immature PIT1-lineage tumors identified from 1084 PitNETs patients over 5 years. Our cohort of 6 males and 9 females had a median age of 37.00 years (range: 23 to 68 y). All patients presented with pituitary macrotumors with an average size of 27.13×22.60×22.13 mm (length×width×height). The invasive growth pattern was identifiable, with 40.00% of tumors presenting with advanced stage (Knosp type 3 and 4) disease, followed by 20.00% Knosp type 2, 26.67% type 1, and 13.33% type 0. Clinical follow-up in 11 patients (median duration: 10.91 mo) revealed local recurrence in 1 case (9.09%). Microscopically, immature PIT1-lineage tumors comprised epithelioid (n=14) or spindle-shaped (n=1) chromophobic or weak basophilic cells with marked cytologic atypia, macronucleoli, and nuclear pseudoinclusions. By immunohistochemistry, most cases showed a consistent stain for PIT1 but limited expression of PIT1 family hormones in conjunction with diffuse or focal expression of CK8/18 (Cam 5.2), whereas none of the mimics showed a similar stain pattern in such a distinct way. We corroborate that immature PIT1-lineage tumors are rare, aggressive, and morphologically unique PitNETs/adenomas with cytologic atypia features. Immunohistochemistry may facilitate diagnosis in the distinction from histologic mimics.

摘要

未成熟的PIT1谱系垂体神经内分泌肿瘤(PitNETs)/腺瘤(未成熟的PIT1谱系肿瘤)是PitNETs中一种罕见且未被充分认识的亚型,具有独特的细胞学异型性特征和侵袭性临床潜能。本研究对5年期间从1084例PitNETs患者中识别出的15例未成熟PIT1谱系肿瘤的临床、放射学、组织学和免疫组化特征进行了描述。我们的队列中有6名男性和9名女性,中位年龄为37.00岁(范围:23至68岁)。所有患者均表现为垂体大肿瘤,平均大小为27.13×22.60×22.13mm(长×宽×高)。侵袭性生长模式可识别,40.00%的肿瘤表现为晚期(Knosp 3型和4型)疾病,其次是20.00%的Knosp 2型、26.67%的1型和13.33%的0型。对11例患者的临床随访(中位持续时间:10.91个月)显示1例(9.09%)局部复发。显微镜下,未成熟的PIT1谱系肿瘤由上皮样(n = 14)或梭形(n = 1)嫌色或弱嗜碱性细胞组成,具有明显的细胞学异型性、大核仁和核假包涵体。通过免疫组化,大多数病例对PIT1呈一致染色,但PIT1家族激素表达有限,同时CK8/18(Cam 5.2)呈弥漫性或局灶性表达,而模拟物均未以如此独特的方式呈现类似的染色模式。我们证实未成熟的PIT1谱系肿瘤是罕见的、侵袭性的且形态学上独特的PitNETs/腺瘤,具有细胞学异型性特征。免疫组化可能有助于与组织学模拟物进行鉴别诊断。

相似文献

1
Immature PIT1-lineage Pituitary Neuroendocrine Tumors/Adenomas, a Morphologically Unique Pituitary Neuroendocrine Tumors/Adenomas Commonly With Cytologic Atypia Features and a Predilection for Aggressive Clinical Potential.未成熟的PIT1谱系垂体神经内分泌肿瘤/腺瘤,一种形态学上独特的垂体神经内分泌肿瘤/腺瘤,通常具有细胞学异型性特征且倾向于具有侵袭性的临床潜能。
Am J Surg Pathol. 2025 Mar 1;49(3):243-250. doi: 10.1097/PAS.0000000000002339. Epub 2024 Dec 17.
2
Multilineage Pituitary Neuroendocrine Tumors Expressing TPIT and SF1: A Clinicopathological Series of Six Tumors.表达TPIT和SF1的多谱系垂体神经内分泌肿瘤:6例肿瘤的临床病理系列研究
Endocr Pathol. 2024 Dec;35(4):349-353. doi: 10.1007/s12022-024-09841-0. Epub 2024 Nov 23.
3
Clinicopathologic Correlates of PIT1 and SF1-Multilineage Pituitary Neuroendocrine Tumors and the Diagnostic Utility of NKX2.2 Immunohistochemistry in Pituitary Pathology.PIT1和SF1多谱系垂体神经内分泌肿瘤的临床病理相关性以及NKX2.2免疫组化在垂体病理学中的诊断效用
Arch Pathol Lab Med. 2025 Jan 1;149(1):83-89. doi: 10.5858/arpa.2023-0543-OA.
4
Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1.表达 PIT1 和 SF1 的多谱系垂体神经内分泌肿瘤(PitNETs)。
Endocr Pathol. 2023 Sep;34(3):273-278. doi: 10.1007/s12022-023-09777-x. Epub 2023 Jun 2.
5
Overview of the 2022 WHO Classification of Pituitary Tumors.《2022 年世卫组织垂体肿瘤分类概述》。
Endocr Pathol. 2022 Mar;33(1):6-26. doi: 10.1007/s12022-022-09703-7. Epub 2022 Mar 15.
6
Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas.静默型 3 型垂体腺瘤并非总是静默的,它们代表分化不良的单型多激素分泌垂体瘤-1 谱系腺瘤。
Mod Pathol. 2016 Feb;29(2):131-42. doi: 10.1038/modpathol.2015.151. Epub 2016 Jan 8.
7
Pituitary neuroendocrine tumors with PIT1/SF1 co-expression show distinct clinicopathological and molecular features.具有PIT1/SF1共表达的垂体神经内分泌肿瘤表现出独特的临床病理和分子特征。
Acta Neuropathol. 2024 Jan 16;147(1):16. doi: 10.1007/s00401-024-02686-1.
8
Comprehensive Classification of Surgically Resected Pituitary Neuroendocrine Tumors: Updates From a Single-Institution Experience Based on the WHO 5th Edition.手术切除垂体神经内分泌肿瘤的综合分类:基于世界卫生组织第5版的单机构经验更新
J Korean Med Sci. 2025 Apr 28;40(16):e56. doi: 10.3346/jkms.2025.40.e56.
9
Tumor immune microenvironment in pituitary neuroendocrine tumors (PitNETs): increased M2 macrophage infiltration and PD-L1 expression in PIT1-lineage subset.垂体神经内分泌肿瘤(PitNETs)中的肿瘤免疫微环境:PIT1 谱系亚群中 M2 巨噬细胞浸润和 PD-L1 表达增加。
J Neurooncol. 2023 Jul;163(3):663-674. doi: 10.1007/s11060-023-04382-8. Epub 2023 Jul 7.
10
Proposal of a clinically relevant working classification of pituitary neuroendocrine tumors based on pituitary transcription factors.基于垂体转录因子的垂体神经内分泌肿瘤临床相关工作分类建议。
Hum Pathol. 2021 Apr;110:20-30. doi: 10.1016/j.humpath.2020.12.001. Epub 2020 Dec 13.

引用本文的文献

1
Ameloblastic Fibro-Odontoma with an FGFR1 Mutation: A Case Report.伴有FGFR1突变的成釉细胞纤维牙瘤:一例报告
Head Neck Pathol. 2025 Feb 5;19(1):19. doi: 10.1007/s12105-025-01758-2.